Funding for this research was provided by:
Canadian Institutes of Health Research (MOP 125918 & PJT 156310)
Natural Sciences and Engineering Research Council of Canada (RGPIN-2016-04549)
University of Calgary
The Lung Association - Alberta & NWT
Text and Data Mining valid from 2019-01-31
Received: 18 May 2018
Accepted: 21 December 2018
First Online: 31 January 2019
Ethics approval and consent to participate
: Participants of the bronchial biopsy study provided written informed consent. The Conjoint Health Research Ethics Board at the University of Calgary and Alberta Health Services approved the study protocol and consent form (ID#23241).
: Not applicable.
: At the time of the study, AML was an employee of AstraZeneca. RN was in receipt of research contracts with AstraZeneca and these funds were used, in part, to support the current study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.